FSGS Recurrence Collaboration Meeting

Save the Date for FSGS Meeting

 

Please Join Us For the Inaugural Virtual FSGS Recurrence Collaboration Meeting

Please register for the conference at:

https://umich.irisregistration.com/Form/FSGS21

December 13 from 1:00 PM - 5:00 PM EST

December 14 from 8:00 AM - 12:00 PM EST

Questions? Email: FSGSRecurrenceCollab@umich.edu

Program committee:

Agenda

All times are listed in eastern standard time.  You can also download this agenda as a PDF.

This 2-day meeting will focus on the critical problem of Recurrent Focal Segmental Glomerulosclerosis in kidney transplant. The primary objectives of this meeting are to identify and prioritize opportunities to advance our understanding of disease mechanisms, expand the foundation for drug development and expand collaborative research focused FSGS recurrence.

Approach: This meeting will prioritize a robust discussion among participants within each session.

December 13, 2021 

1:00 pm - Welcome and Introductions Goals of the Collaborative - Dr. Gipson

1:15 pm - State of the problem

  • FSGS Recurrence Population Perspective:
    Eloise Salmon, M.D. - University of Michigan 
  • Patient/Family Caregiver Perspective
  • Question and Answer Session

2:00 pm - Genetics and FSGS Recurrence - Invited Presentations

  • Pediatric Perspective: Rasheed Gbadegesin, M.D., MBBS - Duke University (Children)
  • Insights from Tango: Leonardo Riello, M.D., Harvard (Adults)
  • Using Genetics to Accelerate Discovery in Kidney Disease TBC
  • Audience - Panel Discussion

3:15 pm - Break

3:30 pm - Identifying Disease Pathways: Podocyte and Beyond

  • Mechanisms of FSGS: Alessia Fornoni, M.D., Ph.D., - University of Miami
  • Immune and Epithelial Cell Cross Talk, TBC
  • Podocyte Loss - Abhijit (Jeet) Naik, MBBS - University of Michigan
  • Audience - Panel Discussion

4:45 pm - Wrap Up

5:00 pm - Conclude

December 14, 2021

8:00 am - Welcome

8:05 am - Identifying Disease Pathways and Modifiers

  • HLA Biology: Annette Jackson, Ph.D. - Duke University
  • APOL1 Nephropathy: Opeyemi Ofabisi, M.D., Ph.d. - Duke University
  • Audience - Panel Discussion

9:10 am - Exploring Disease Mechanisms: Methodology

  • Methods: High sensitivity flow cytometry - Andrew Malone, MB, BCh - Washington University, St. Louis
  • Methods: Organoids: Benjamin Freedman, Ph.D., University of Washington, Seattle
  • Methods: Organoids: Jennifer Harder, M.D. - University of Michigan 
  • Methods: Proteomics: Jon Klein, M.D., Ph.D. - University of Louisville
  • Audience - Panel Discussion

10:30 am - Break

10:50 am - Therapy Development & Rare Disease Trial Design [Session Chair: Howard Trachtman]

  • Lessons learned from Trials: Speaker George Burke, M.D.
  • Panelists: George Burke, Michelle Rheault, Catherine Spino, Kelley Kidwell
  • Audience - Panel Discussion 

11:40 pm - Next Steps - Dr. Gipson

12:00 pm - Conclude